Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography (ERAP)

NCT06022068 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT06022068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06022068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography (ERAP)
Lead sponsor
Karolinska Institutet
Phase
Phase 1/2
Overall status
Completed
Start date
September 1, 2023
Completion date
January 17, 2025
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease